Berger Raanan, Febbo Phillip G, Majumder Pradip K, Zhao Jean J, Mukherjee Shayan, Signoretti Sabina, Campbell K Thirza, Sellers William R, Roberts Thomas M, Loda Massimo, Golub Todd R, Hahn William C
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Cancer Res. 2004 Dec 15;64(24):8867-75. doi: 10.1158/0008-5472.CAN-04-2938.
Androgen ablation is the primary treatment modality for patients with metastatic prostate cancer; however, the role of androgen receptor signaling in prostate cancer development remains enigmatic. Using a series of genetically defined immortalized and tumorigenic human prostate epithelial cells, we found that introduction of the androgen receptor induced differentiation of transformed prostate epithelial cells to a luminal phenotype reminiscent of organ-confined prostate cancer when placed in the prostate microenvironment. Moreover, androgen receptor expression converted previously androgen-independent, tumorigenic prostate epithelial cells into cells dependent on testosterone for tumor formation. These observations indicate that androgen receptor expression is oncogenic and addictive for the human prostate epithelium.
雄激素剥夺是转移性前列腺癌患者的主要治疗方式;然而,雄激素受体信号传导在前列腺癌发展中的作用仍然不明。通过一系列基因定义的永生化和致瘤性人前列腺上皮细胞,我们发现,当置于前列腺微环境中时,引入雄激素受体可诱导转化的前列腺上皮细胞分化为管腔表型,类似于器官局限性前列腺癌。此外,雄激素受体表达将先前雄激素非依赖性的致瘤性前列腺上皮细胞转变为依赖睾酮形成肿瘤的细胞。这些观察结果表明,雄激素受体表达对人前列腺上皮具有致癌性且具有成瘾性。